190 related articles for article (PubMed ID: 34521389)
1. Multimorbidity and achievement of treatment goals among patients with type 2 diabetes: a primary care, real-world study.
Heikkala E; Mikkola I; Jokelainen J; Timonen M; Hagnäs M
BMC Health Serv Res; 2021 Sep; 21(1):964. PubMed ID: 34521389
[TBL] [Abstract][Full Text] [Related]
2. Multimorbidity, mortality, and HbA1c in type 2 diabetes: A cohort study with UK and Taiwanese cohorts.
Chiang JI; Hanlon P; Li TC; Jani BD; Manski-Nankervis JA; Furler J; Lin CC; Yang SY; Nicholl BI; Thuraisingam S; Mair FS
PLoS Med; 2020 May; 17(5):e1003094. PubMed ID: 32379755
[TBL] [Abstract][Full Text] [Related]
3. Associations between multimorbidity and glycaemia (HbA1c) in people with type 2 diabetes: cross-sectional study in Australian general practice.
Chiang JI; Furler J; Mair F; Jani BD; Nicholl BI; Thuraisingam S; Manski-Nankervis JA
BMJ Open; 2020 Nov; 10(11):e039625. PubMed ID: 33243798
[TBL] [Abstract][Full Text] [Related]
4. Association of musculoskeletal pain with the achievement of treatment targets for type 2 diabetes among primary care patients.
Heikkala E; Hagnäs M; Jokelainen J; Karppinen J; Ferreira P; Ferreira ML; Mikkola I
Prim Care Diabetes; 2022 Aug; 16(4):531-536. PubMed ID: 35523651
[TBL] [Abstract][Full Text] [Related]
5. Paradox of glycemic management: multimorbidity, glycemic control, and high-risk medication use among adults with diabetes.
McCoy RG; Lipska KJ; Van Houten HK; Shah ND
BMJ Open Diabetes Res Care; 2020 Feb; 8(1):. PubMed ID: 32075810
[TBL] [Abstract][Full Text] [Related]
6. Multimorbidity, glycaemic variability and time in target range in people with type 2 diabetes: A baseline analysis of the GP-OSMOTIC trial.
Chiang JI; Manski-Nankervis JA; Thuraisingam S; Jenkins A; O'Neal D; Mair FS; Jani BD; Nicholl BI; Furler J
Diabetes Res Clin Pract; 2020 Nov; 169():108451. PubMed ID: 32949650
[TBL] [Abstract][Full Text] [Related]
7. Eleven-year multimorbidity burden among 637 255 people with and without type 2 diabetes: a population-based study using primary care and linked hospitalisation data.
Zghebi SS; Steinke DT; Rutter MK; Ashcroft DM
BMJ Open; 2020 Jul; 10(7):e033866. PubMed ID: 32611677
[TBL] [Abstract][Full Text] [Related]
8. Association of personalised care plans with monitoring and control of clinical outcomes, prescription of medication and utilisation of primary care services in patients with type 2 diabetes: an observational real-world study.
Mikkola I; Morgan S; Winell K; Jokelainen J; Frittitta L; Heikkala E; Hagnäs M
Scand J Prim Health Care; 2022 Mar; 40(1):39-47. PubMed ID: 35148662
[TBL] [Abstract][Full Text] [Related]
9. Determinants of health-related quality of life of patients with type 2 diabetes and multimorbidity: a cross-sectional study.
Kintzoglanakis K; Pavlou-Skantzis L; Themeli T; Kyprianou M; Paschou SA
Hormones (Athens); 2024 Mar; ():. PubMed ID: 38485876
[TBL] [Abstract][Full Text] [Related]
10. Cardiovascular events and mortality in people with type 2 diabetes and multimorbidity: A real-world study of patients followed for up to 19 years.
Coles B; Zaccardi F; Hvid C; Davies MJ; Khunti K
Diabetes Obes Metab; 2021 Jan; 23(1):218-227. PubMed ID: 33026165
[TBL] [Abstract][Full Text] [Related]
11. Medication Adherence and Blood Pressure Control Among Hypertensive Patients With Coexisting Long-Term Conditions in Primary Care Settings: A Cross-Sectional Analysis.
Li YT; Wang HHX; Liu KQL; Lee GKY; Chan WM; Griffiths SM; Chen RL
Medicine (Baltimore); 2016 May; 95(20):e3572. PubMed ID: 27196458
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and incidence density rates of chronic comorbidity in type 2 diabetes patients: an exploratory cohort study.
Luijks H; Schermer T; Bor H; van Weel C; Lagro-Janssen T; Biermans M; de Grauw W
BMC Med; 2012 Oct; 10():128. PubMed ID: 23106808
[TBL] [Abstract][Full Text] [Related]
13. The impact of a patient's concordant and discordant chronic conditions on diabetes care quality measures.
Magnan EM; Palta M; Johnson HM; Bartels CM; Schumacher JR; Smith MA
J Diabetes Complications; 2015 Mar; 29(2):288-94. PubMed ID: 25456821
[TBL] [Abstract][Full Text] [Related]
14. Recurrent prescription of sleep medication among primary care patients with type 2 diabetes: an observational study of real-world registry data.
Heikkala E; Jokelainen J; Mikkola I; Auvinen J; Hagnäs M
BMC Prim Care; 2023 Apr; 24(1):90. PubMed ID: 37016350
[TBL] [Abstract][Full Text] [Related]
15. Mode of treatments and achievement of treatment targets among type 2 diabetes patients with different comorbidities - a register-based retrospective cohort study in Finland.
Nazu NA; Wikström K; Lamidi ML; Lindström J; Tirkkonen H; Rautiainen P; Laatikainen T
BMC Prim Care; 2022 Nov; 23(1):278. PubMed ID: 36352358
[TBL] [Abstract][Full Text] [Related]
16. Epidemiology of multimorbidity in conditions of extreme poverty: a population-based study of older adults in rural Burkina Faso.
Odland ML; Payne C; Witham MD; Siedner MJ; Bärnighausen T; Bountogo M; Coulibaly B; Geldsetzer P; Harling G; Manne-Goehler J; Ouermi L; Sie A; Davies JI
BMJ Glob Health; 2020; 5(3):e002096. PubMed ID: 32337079
[TBL] [Abstract][Full Text] [Related]
17. Does the impact of case management vary in different subgroups of multimorbidity? Secondary analysis of a quasi-experiment.
Stokes J; Kristensen SR; Checkland K; Cheraghi-Sohi S; Bower P
BMC Health Serv Res; 2017 Aug; 17(1):521. PubMed ID: 28774296
[TBL] [Abstract][Full Text] [Related]
18. Psychosocial complexity in multimorbidity: the legacy of adverse childhood experiences.
Sinnott C; Mc Hugh S; Fitzgerald AP; Bradley CP; Kearney PM
Fam Pract; 2015 Jun; 32(3):269-75. PubMed ID: 25900675
[TBL] [Abstract][Full Text] [Related]
19. Impact of the Prevalence of Concordant and Discordant Conditions on the Quality of Diabetes Care in Family Practices in England.
Ricci-Cabello I; Stevens S; Kontopantelis E; Dalton AR; Griffiths RI; Campbell JL; Doran T; Valderas JM
Ann Fam Med; 2015 Nov; 13(6):514-22. PubMed ID: 26553890
[TBL] [Abstract][Full Text] [Related]
20. Association of Patient-Physician Language Concordance and Glycemic Control for Limited-English Proficiency Latinos With Type 2 Diabetes.
Parker MM; Fernández A; Moffet HH; Grant RW; Torreblanca A; Karter AJ
JAMA Intern Med; 2017 Mar; 177(3):380-387. PubMed ID: 28114680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
